We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (CoRDS)

This study is currently recruiting participants.
Verified September 2016 by Sanford Health
Sponsor:
ClinicalTrials.gov Identifier:
NCT01793168
First Posted: February 15, 2013
Last Update Posted: October 2, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
National Ataxia Foundation
International WAGR Syndrome Association
4p- Support Group
ML4 Foundation
Cornelia de Lange Syndrome Foundation
Stickler Involved People
Kawasaki Disease Foundation
Klippel-Feil Syndrome Alliance
Klippel-Feil Syndrome Freedom
Hyperacusis Research Limited
Hypersomnia Foundation
Kabuki Syndrome Network
Kleine-Levin Syndrome Foundation
Leiomyosarcoma Direct Research Foundation
Marinesco-Sjogren Syndrome Support Group
Mucolipidosis Type IV (ML4) Foundation
People with Narcolepsy 4 People with Narcolepsy (PWN4PWN)
Soft Bones Incorporated
American Multiple Endocrine Neoplasia Support
Atypical Hemolytic Uremic Syndrome Foundation
All Things Kabuki
Wiedemann-Steiner Syndrome Foundation
Breast Implant Victim Advocates
PROS Foundation
American Behcet's Disease Association
Information provided by (Responsible Party):
Sanford Health
  Purpose
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access. Visit sanfordresearch.org/CoRDS to enroll.

Condition
Rare Disorders Undiagnosed Disorders Disorders of Unknown Prevalence Cornelia De Lange Syndrome Prenatal Benign Hypophosphatasia Perinatal Lethal Hypophosphatasia Odontohypophosphatasia Adult Hypophosphatasia Childhood-onset Hypophosphatasia Infantile Hypophosphatasia Hypophosphatasia Kabuki Syndrome Bohring-Opitz Syndrome Narcolepsy Without Cataplexy Narcolepsy-cataplexy Hypersomnolence Disorder Idiopathic Hypersomnia Without Long Sleep Time Idiopathic Hypersomnia With Long Sleep Time Idiopathic Hypersomnia Kleine-Levin Syndrome Kawasaki Disease Leiomyosarcoma Leiomyosarcoma of the Corpus Uteri Leiomyosarcoma of the Cervix Uteri Leiomyosarcoma of Small Intestine Acquired Myasthenia Gravis Addison Disease Hyperacusis (Hyperacousis) Juvenile Myasthenia Gravis Transient Neonatal Myasthenia Gravis Williams Syndrome Lyme Disease Myasthenia Gravis Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome) Isolated Klippel-Feil Syndrome Frasier Syndrome Denys-Drash Syndrome Beckwith-Wiedemann Syndrome Emanuel Syndrome Isolated Aniridia Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11 Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15 Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion Axenfeld-Rieger Syndrome Aniridia-intellectual Disability Syndrome Aniridia - Renal Agenesis - Psychomotor Retardation Aniridia - Ptosis - Intellectual Disability - Familial Obesity Aniridia - Cerebellar Ataxia - Intellectual Disability Aniridia - Absent Patella Aniridia Peters Anomaly - Cataract Peters Anomaly Potocki-Shaffer Syndrome Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11 Silver-Russell Syndrome Due to Imprinting Defect of 11p15 Silver-Russell Syndrome Due to 11p15 Microduplication Syndromic Aniridia WAGR Syndrome Wolf-Hirschhorn Syndrome 4p16.3 Microduplication Syndrome 4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome Autosomal Recessive Stickler Syndrome Stickler Syndrome Type 2 Stickler Syndrome Type 1 Stickler Syndrome Mucolipidosis Type 4 X-linked Spinocerebellar Ataxia Type 4 X-linked Spinocerebellar Ataxia Type 3 X-linked Intellectual Disability - Ataxia - Apraxia X-linked Progressive Cerebellar Ataxia X-linked Non Progressive Cerebellar Ataxia X-linked Cerebellar Ataxia Vitamin B12 Deficiency Ataxia Toxic Exposure Ataxia Unclassified Autosomal Dominant Spinocerebellar Ataxia Thyroid Antibody Ataxia Sporadic Adult-onset Ataxia of Unknown Etiology Spinocerebellar Ataxia With Oculomotor Anomaly Spinocerebellar Ataxia With Epilepsy Spinocerebellar Ataxia With Axonal Neuropathy Type 2 Spinocerebellar Ataxia Type 8 Spinocerebellar Ataxia Type 7 Spinocerebellar Ataxia Type 6 Spinocerebellar Ataxia Type 5 Spinocerebellar Ataxia Type 4 Spinocerebellar Ataxia Type 37 Spinocerebellar Ataxia Type 36 Spinocerebellar Ataxia Type 35 Spinocerebellar Ataxia Type 34 Spinocerebellar Ataxia Type 32 Spinocerebellar Ataxia Type 31 Spinocerebellar Ataxia Type 30 Spinocerebellar Ataxia Type 3 Spinocerebellar Ataxia Type 29 Spinocerebellar Ataxia Type 28 Spinocerebellar Ataxia Type 27 Spinocerebellar Ataxia Type 26 Spinocerebellar Ataxia Type 25 Spinocerebellar Ataxia Type 23 Spinocerebellar Ataxia Type 22 Spinocerebellar Ataxia Type 21 Spinocerebellar Ataxia Type 20 Spinocerebellar Ataxia Type 2 Spinocerebellar Ataxia Type 19/22 Spinocerebellar Ataxia Type 18 Spinocerebellar Ataxia Type 17 Spinocerebellar Ataxia Type 16 Spinocerebellar Ataxia Type 15/16 Spinocerebellar Ataxia Type 14 Spinocerebellar Ataxia Type 13 Spinocerebellar Ataxia Type 12 Spinocerebellar Ataxia Type 11 Spinocerebellar Ataxia Type 10 Spinocerebellar Ataxia Type 1 With Axonal Neuropathy Spinocerebellar Ataxia Type 1 Spinocerebellar Ataxia - Unknown Spinocerebellar Ataxia - Dysmorphism Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature Spectrin-associated Autosomal Recessive Cerebellar Ataxia Spasticity-ataxia-gait Anomalies Syndrome Spastic Ataxia With Congenital Miosis Spastic Ataxia - Corneal Dystrophy Spastic Ataxia Rare Hereditary Ataxia Rare Ataxia Recessive Mitochondrial Ataxia Syndrome Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature Posterior Column Ataxia - Retinitis Pigmentosa Post-Stroke Ataxia Post-Head Injury Ataxia Post Vaccination Ataxia Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus Non-progressive Cerebellar Ataxia With Intellectual Disability Non-hereditary Degenerative Ataxia Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity Olivopontocerebellar Atrophy - Deafness NARP Syndrome Myoclonus - Cerebellar Ataxia - Deafness Multiple System Atrophy, Parkinsonian Type Multiple System Atrophy, Cerebellar Type Multiple System Atrophy Maternally-inherited Leigh Syndrome Machado-Joseph Disease Type 3 Machado-Joseph Disease Type 2 Machado-Joseph Disease Type 1 Lethal Ataxia With Deafness and Optic Atrophy Leigh Syndrome Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination Leigh Syndrome With Nephrotic Syndrome Leigh Syndrome With Leukodystrophy Leigh Syndrome With Cardiomyopathy Late-onset Ataxia With Dementia Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome Infection or Post Infection Ataxia Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia Infantile Onset Spinocerebellar Ataxia GAD Ataxia Hereditary Episodic Ataxia Gliadin/Gluten Ataxia Friedreich Ataxia Fragile X-associated Tremor/Ataxia Syndrome Familial Paroxysmal Ataxia Exposure to Medications Ataxia Episodic Ataxia With Slurred Speech Episodic Ataxia Unknown Type Episodic Ataxia Type 7 Episodic Ataxia Type 6 Episodic Ataxia Type 5 Episodic Ataxia Type 4 Episodic Ataxia Type 3 Episodic Ataxia Type 1 Epilepsy and/or Ataxia With Myoclonus as Major Feature Early-onset Spastic Ataxia-neuropathy Syndrome Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity Early-onset Cerebellar Ataxia With Retained Tendon Reflexes Early-onset Ataxia With Dementia Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia Dilated Cardiomyopathy With Ataxia Cataract - Ataxia - Deafness Cerebellar Ataxia, Cayman Type Cerebellar Ataxia With Peripheral Neuropathy Cerebellar Ataxia - Hypogonadism Cerebellar Ataxia - Ectodermal Dysplasia Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss Brain Tumor Ataxia Brachydactyly - Nystagmus - Cerebellar Ataxia Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia Autosomal Recessive Syndromic Cerebellar Ataxia Autosomal Recessive Spastic Ataxia With Leukoencephalopathy Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria Autosomal Recessive Spastic Ataxia Autosomal Recessive Metabolic Cerebellar Ataxia Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine Autosomal Recessive Ataxia, Beauce Type Autosomal Recessive Ataxia Due to Ubiquinone Deficiency Autosomal Recessive Ataxia Due to PEX10 Deficiency Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency Autosomal Recessive Congenital Cerebellar Ataxia Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness Autosomal Recessive Cerebellar Ataxia Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy Autosomal Dominant Spastic Ataxia Type 1 Autosomal Dominant Spastic Ataxia Autosomal Dominant Optic Atrophy Ataxia-telangiectasia Variant Ataxia-telangiectasia Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy Autosomal Dominant Cerebellar Ataxia Type 4 Autosomal Dominant Cerebellar Ataxia Type 3 Autosomal Dominant Cerebellar Ataxia Type 2 Autosomal Dominant Cerebellar Ataxia Type 1 Autosomal Dominant Cerebellar Ataxia Ataxia-telangiectasia-like Disorder Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome Ataxia-deafness-intellectual Disability Syndrome Ataxia With Vitamin E Deficiency Ataxia With Dementia Ataxia Neuropathy Spectrum Ataxia - Tapetoretinal Degeneration Ataxia - Photosensitivity - Short Stature Ataxia - Pancytopenia Ataxia - Oculomotor Apraxia Type 1 Ataxia - Hypogonadism - Choroidal Dystrophy Ataxia - Other Ataxia - Genetic Diagnosis - Unknown Acquired Ataxia Adult-onset Autosomal Recessive Cerebellar Ataxia Alcohol Related Ataxia Multiple Endocrine Neoplasia Multiple Endocrine Neoplasia Type II Multiple Endocrine Neoplasia Type 1 Multiple Endocrine Neoplasia Type 2 Multiple Endocrine Neoplasia, Type IV Multiple Endocrine Neoplasia, Type 3 Multiple Endocrine Neoplasia (MEN) Syndrome Multiple Endocrine Neoplasia Type 2B Multiple Endocrine Neoplasia Type 2A Atypical Hemolytic Uremic Syndrome Atypical HUS Wiedemann-Steiner Syndrome Breast Implant-Associated Anaplastic Large Cell Lymphoma Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA) Hemophagocytic Lymphohistiocytosis Behcet's Disease

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration: 100 Years
Official Title: Coordination of Rare Diseases at Sanford

Resource links provided by NLM:

Genetics Home Reference related topics: Axenfeld-Rieger syndrome Beckwith-Wiedemann syndrome Behçet disease CASK-related intellectual disability Cornelia de Lange syndrome Denys-Drash syndrome Emanuel syndrome Frasier syndrome Gillespie syndrome Kawasaki disease Klippel-Feil syndrome Leigh syndrome Marinesco-Sjögren syndrome Peters anomaly Potocki-Shaffer syndrome Russell-Silver syndrome SYNGAP1-related intellectual disability Silver syndrome Sjögren syndrome Stickler syndrome VLDLR-associated cerebellar hypoplasia WAGR syndrome Wolf-Hirschhorn syndrome aniridia ataxia with vitamin E deficiency ataxia-telangiectasia atypical hemolytic-uremic syndrome autosomal recessive cerebellar ataxia type 1 autosomal recessive spastic ataxia of Charlevoix-Saguenay cone-rod dystrophy episodic ataxia familial dilated cardiomyopathy hypophosphatasia infantile-onset spinocerebellar ataxia mucolipidosis type IV multiple endocrine neoplasia multiple system atrophy myasthenia gravis narcolepsy nonsyndromic hearing loss optic atrophy type 1 primary coenzyme Q10 deficiency pyridoxal 5'-phosphate-dependent epilepsy retinitis pigmentosa spinocerebellar ataxia type 1 spinocerebellar ataxia type 2 spinocerebellar ataxia type 3 spinocerebellar ataxia type 36 spinocerebellar ataxia type 6
MedlinePlus related topics: Rare Diseases
Genetic and Rare Diseases Information Center resources: Lymphosarcoma Spinocerebellar Ataxia Leukodystrophy Neuronal Ceroid Lipofuscinosis Narcolepsy Retinitis Pigmentosa Cone-rod Dystrophy Cone-rod Dystrophy 2 Apraxia Myasthenia Gravis Hemophagocytic Lymphohistiocytosis Bohring-Opitz Syndrome Hemolytic Uremic Syndrome Atypical Hemolytic Uremic Syndrome Friedreich Ataxia Multiple System Atrophy Behçet Disease Dilated Cardiomyopathy Leiomyosarcoma Addison's Disease Hyperacusis Lymphoma, Large-cell Anaplastic Large Cell Lymphoma Kawasaki Disease Klippel Feil Syndrome Leigh Syndrome Spinocerebellar Ataxia 1 Cogan's Syndrome Spinocerebellar Ataxia 2 Spinocerebellar Ataxia 3 Spinocerebellar Ataxia With Axonal Neuropathy Type 2 Cornelia De Lange Syndrome Renal Agenesis Potter Syndrome Multiple Endocrine Neoplasia Type 2 Multiple Endocrine Neoplasia Type 2A Multiple Endocrine Neoplasia Type 1 Spinocerebellar Ataxia Type 6 Spinocerebellar Ataxia 7 Spinocerebellar Ataxia 10 Spinocerebellar Ataxia 8 Aniridia Idiopathic Hypersomnia Ectodermal Dysplasia Ataxia Telangiectasia Williams Syndrome Multiple Endocrine Neoplasia Type 2B Hypophosphatasia Kleine Levin Syndrome Mucolipidosis Type 4 Beckwith-Wiedemann Syndrome Fetal Thalidomide Syndrome Russell-Silver Syndrome Diencephalic Syndrome Episodic Ataxia Kabuki Syndrome Hereditary Ataxia Stickler Syndrome Autosomal Dominant Cerebellar Ataxia WAGR Syndrome Dominant Optic Atrophy Optic Atrophy 1 Marinesco-Sjogren Syndrome Denys-Drash Syndrome Peters Anomaly Frasier Syndrome Uniparental Disomy of Chromosome 11 Spinocerebellar Ataxia 4 Mitochondrial DNA-associated Leigh Syndrome Olivopontocerebellar Atrophy Thomas Syndrome Wolf-Hirschhorn Syndrome Childhood Hypophosphatasia Emanuel Syndrome Axenfeld-Rieger Syndrome Aniridia - Ptosis - Intellectual Disability - Familial Obesity Absent Patella Potocki-Shaffer Syndrome Stickler Syndrome, Type 2 Stickler Syndrome Type 1 Spinocerebellar Ataxia Autosomal Recessive With Axonal Neuropathy Spinocerebellar Ataxia 5 Spinocerebellar Ataxia 34 Spinocerebellar Ataxia 31 Spinocerebellar Ataxia 30 Spinocerebellar Ataxia 29 Spinocerebellar Ataxia 28 Spinocerebellar Ataxia 27 Spinocerebellar Ataxia 26 Spinocerebellar Ataxia 25 Spinocerebellar Ataxia 23 Spinocerebellar Ataxia 21 Spinocerebellar Ataxia 20 Spinocerebellar Ataxia 18 Spinocerebellar Ataxia 17 Spinocerebellar Ataxia 15 Spinocerebellar Ataxia 14 Spinocerebellar Ataxia 13 Spinocerebellar Ataxia 12 Spinocerebellar Ataxia 11 Microcoria, Congenital Posterior Column Ataxia Neuropathy Ataxia Retinitis Pigmentosa Syndrome Arts Syndrome Infantile Onset Spinocerebellar Ataxia Spinocerebellar Ataxia Autosomal Recessive 7 DCMA Syndrome Cerebellar Ataxia and Hypogonadotropic Hypogonadism Cerebellar Ataxia Ectodermal Dysplasia Biemond Syndrome Spastic Ataxia Charlevoix-Saguenay Type Autosomal Recessive Spastic Ataxia 4 Autosomal Recessive Spinocerebellar Ataxia 9 Coenzyme Q10 Deficiency Spinocerebellar Ataxia Autosomal Recessive 3 Autosomal Dominant Cerebellar Ataxia, Deafness, and Narcolepsy Ataxia With Vitamin E Deficiency Ataxia - Hypogonadism - Choroidal Dystrophy Wiedemann-Steiner Syndrome Mucopolysaccharidosis Type IV Anodontia Paraplegia Microcephaly Microencephaly Soft Tissue Sarcoma Panuveitis Uveal Diseases Familial Mediterranean Fever Ocular Motility Disorders Motor Neuro-ophthalmic Disorders Hypoadrenalism Aortic Valve Stenosis Wilms' Tumor Charcot-Marie-Tooth Disease Hereditary Neuropathy With Liability to Pressure Palsy Roussy Levy Syndrome
U.S. FDA Resources

Further study details as provided by Sanford Health:

Primary Outcome Measures:
  • To accelerate research into rare disorders by connecting individuals who are interested in research and who have been diagnosed with a rare disorder (or a disorder of unknown prevalence, or who are undiagnosed) with researchers who study rare diseases. [ Time Frame: 100 years ]

Biospecimen Retention:   None Retained
Biospecimen collection capability anticipated in 2014.

Estimated Enrollment: 20000
Study Start Date: July 2010
Estimated Study Completion Date: December 2100
Estimated Primary Completion Date: December 2100 (Final data collection date for primary outcome measure)
Detailed Description:

CoRDS collects contact, sociodemographic and health information about participants. This information is entered into CoRDS and linked to a unique coded identifier. Below are some examples of information requested on the Questionnaire that will be entered into CoRDS:

  • Contact information: Name, Mailing Address, Phone Number, Email Address
  • Sociodemographic information: Date of Birth, Place of Birth, Sex, Gender, Ethnicity
  • Health information: Family History, Information related to Diagnosis

De-identified information in CoRDS will be made available to researchers, if they have obtained approval for their research project from (1) the Institutional Review Board (IRB) at the researcher's institution and (2) a panel of experts.

A subset of de-identified information collected from each profile may be shared with certain other databases. This is done in order to help improve understanding of rare diseases, to avoid the duplication of efforts and to collaborate with existing research efforts with organizations dedicated to rare diseases.

Participants may elect to have their information shared with patient advocacy groups (PAGs) representing individuals with rare or uncommon diseases who have partnered with CoRDS. The PAG will sign an agreement stating that they will not use the information for Research purposes. CoRDS personnel will not be held responsible for the use of information by the PAG.

The CoRDS Registry will not be paid by Researchers, Other Patient Registries or Patient Advocacy Groups (PAGs) for access to information in CoRDS.

If a parent/LAR consents on behalf of a minor, CoRDS will contact the participant when he or she reaches the age of 18 in order to obtain consent. If this consent is not obtained in a timely manner, the participant will be withdrawn from CoRDS.

CoRDS contacts participants annually to confirm continued interest in participation in CoRDS, and to request that participants update the information they have provided.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Unaffected carriers, undiagnosed and those with a rare disease or rare condition.
Criteria

Inclusion Criteria:

  • Diagnosis of a rare disease, a disease of unknown prevalence, undiagnosed or an unaffected carrier of a rare/uncommon disease

Exclusion Criteria:

  • Diagnosis of a disease which is not rare
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01793168


Contacts
Contact: CoRDS Team 1-877-658-9192 cords@sanfordhealth.org

Locations
United States, South Dakota
Sanford Health Recruiting
Sioux Falls, South Dakota, United States, 57104
Contact: CoRDS Team    877-658-9192    cords@sanfordhealth.org   
Principal Investigator: Jill Weimer, PhD         
Sponsors and Collaborators
Sanford Health
National Ataxia Foundation
International WAGR Syndrome Association
4p- Support Group
ML4 Foundation
Cornelia de Lange Syndrome Foundation
Stickler Involved People
Kawasaki Disease Foundation
Klippel-Feil Syndrome Alliance
Klippel-Feil Syndrome Freedom
Hyperacusis Research Limited
Hypersomnia Foundation
Kabuki Syndrome Network
Kleine-Levin Syndrome Foundation
Leiomyosarcoma Direct Research Foundation
Marinesco-Sjogren Syndrome Support Group
Mucolipidosis Type IV (ML4) Foundation
People with Narcolepsy 4 People with Narcolepsy (PWN4PWN)
Soft Bones Incorporated
American Multiple Endocrine Neoplasia Support
Atypical Hemolytic Uremic Syndrome Foundation
All Things Kabuki
Wiedemann-Steiner Syndrome Foundation
Breast Implant Victim Advocates
PROS Foundation
American Behcet's Disease Association
  More Information

Additional Information:
Responsible Party: Sanford Health
ClinicalTrials.gov Identifier: NCT01793168     History of Changes
Other Study ID Numbers: 03-10-014
Hypersomnia Foundation ( Registry Identifier: Hypersomnia Registry )
National Ataxia Foundation ( Registry Identifier: Ataxia Registry )
4p- Support Group ( Registry Identifier: 4p-/Wolfhirschhorn Syndrome Registry )
CdLS Foundation ( Registry Identifier: Cornelia de Lange Syndrome Registry )
Hyperacusis Research Limited ( Registry Identifier: Hyperacusis Registry )
Kabuki Syndrome Network ( Registry Identifier: Kabuki Syndrome Registry )
Kawasaki Disease Foundation ( Registry Identifier: Kawasaki Disease Registry )
Klippel-Feil Syndrome Freedom ( Registry Identifier: Klippel-Feil Syndrome Registry )
Leiomyosarcoma Direct Research ( Registry Identifier: Leiomyosarcoma Registry )
MSS Support Group ( Registry Identifier: Marinesco-Sjogren Syndrome Registry )
ML4 Foundation ( Registry Identifier: Mucolipidosis Type IV (ML4) Registry )
Stickler Involved People ( Registry Identifier: Stickler Syndrome Registry )
IWSA ( Registry Identifier: WAGR Syndrome Registry )
Soft Bones ( Registry Identifier: Hypophosphatasia Registry )
PWN4PWN ( Registry Identifier: Narcolepsy Registry )
aHUS ( Registry Identifier: aHUS Registry )
Klippel-Feil Syndrome Alliance ( Registry Identifier: KFS Registry )
American MEN Support ( Registry Identifier: Mulitiple Endocrine Neoplasia Registry )
Kleine-Levin Syndrome ( Registry Identifier: Kleine-Levin Syndrome Registry )
All Things Kabuki ( Registry Identifier: Kabuki Syndrome Registry )
WSS Foundation ( Registry Identifier: Wiedemann-Steiner Syndrome Registry )
BIVA ( Registry Identifier: Brest Implant-Associated ALCL Registry )
ABDA ( Registry Identifier: American Bechet's Disease Association Registry )
PROS Foundation (HLH) ( Registry Identifier: Hemophagocytic Lymphohistiocytosis (HLH) Registry )
First Submitted: February 13, 2013
First Posted: February 15, 2013
Last Update Posted: October 2, 2017
Last Verified: September 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Deidentified participant data is shared with contracted patient advocacy groups for non-research purposes. Parties interested in accessing data are welcome to apply (cost-free) at http://www.sanfordresearch.org/cords/researchers/.

Keywords provided by Sanford Health:
Rare Diseases
Neglected Diseases
Orphan Diseases
Rare Disease Research
Registries
WAGR Syndrome
Ataxia
Cornelia de Lange Syndrome
Stickler Syndrome
Ataxia Telangiectasia
Kawasaki Disease
Batten Disease
Mucolipidosis IV
Klippel-Feil Syndrome
Multiple Endocrine Neoplasia
Atypical Hemolytic Uremic Syndrome
Undiagnosed
Uncommon Disease
Kabuki Syndrome
Hypersomnia
Hyperacusis
Kleine-Levin Syndrome
Marinesco-Sjogren Syndrome
Leiomyosarcoma
4p-/Wolf-Hirschhorn Syndrome
Hypophosphatasia
Narcolepsy
Wiedermann-Steiner Syndrome
Breast Implant-Associated Anaplastic Large Cell Lymphoma
Autoimmune/inflammatory Syndrome Induced by Adjuvants (ASIA)

Additional relevant MeSH terms:
Disease
Syndrome
Diabetes Mellitus
Epilepsy
Dementia
Peripheral Nervous System Diseases
Cataract
Cardiomyopathies
Atrophy
Neoplasms
Muscle Spasticity
Hearing Loss
Deafness
Ataxia
Cerebellar Ataxia
Hypogonadism
Retinitis
Lymphoma, Large-Cell, Anaplastic
Rare Diseases
Sjogren's Syndrome
Polyneuropathies
Muscular Atrophy
Retinitis Pigmentosa
Cone-Rod Dystrophies
Telangiectasis
Cardiomyopathy, Dilated
Leiomyosarcoma
Congenital Abnormalities
Nephrotic Syndrome
Nephrosis